Citadel Advisors - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q1 2023$52,708
-18.4%
15,548
-13.1%
0.00%
Q4 2022$64,587
-39.6%
17,891
+57.8%
0.00%
Q1 2022$107,000
-5.3%
11,339
-4.5%
0.00%
Q3 2021$113,00011,8690.00%
Other shareholders
LUMOS PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Acuitas Investments, LLC 125,242$413,2990.24%
Lion Point Capital, LP 90,794$299,6200.13%
Greenwich Wealth Management LLC 76,341$2520.03%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 25,760$85,0080.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
Leucadia National 120,651$398,1480.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders